Today’s virtual Annual General Meeting of Alzchem Group AG expressed its continued confidence in the Management Board and the Supervisory Board by discharging them for the fiscal year 2021 and approved all agenda items with a large majority.
We have more than 60 years of experience in the development and manufacture of advanced, high-quality intermediates for pharmaceutical applications.
Our customers benefit from the following advantages in the pharmaceutical sector:
- Reliability & consistently high quality
- Our customer orientation
- Sustainability, Health & Safety
- Our know-how